Prediction and analysis of albumin-bilirubin score combined with liver function index and carcinoembryonic antigen on liver metastasis of colorectal cancer

Figure 1 Patient inclusion and randomization flow charts.

Figure 2 Feature variable selection based on least absolute shrinkage and selection operator regression. A: Tenfold cross-validation chart; B: Shrinkage coefficient chart.

Figure 3 Receiver operating characteristic curve of the model for predicting liver metastasis in patients with colorectal cancer. A: Modeling group; B: Verification group. ALT: Alanine aminotransferase; CEA: Carcinoembryonic antigen; ALBI: Albumin-bilirubin.

Figure 4 Calibration curves of the least absolute shrinkage and selection operator logistic regression model. A: Modeling group; B: Verification group.

Figure 5 Decision curve analysis of the least absolute shrinkage and selection operator logistic regression model. A: Modeling group; B: Verification group.

Figure 6 Nomogram prediction model for liver metastasis of colorectal cancer. ALT: Alanine aminotransferase; CEA: Carcinoembryonic antigen; ALBI: Albumin-bilirubin.